LRRC59 and colonic neoplasm: Differential expression of LRRC59 in pan‐cancers was analyzed based on TIMER database, and the result showed that LRRC59 expression was elevated in bladder, breast, colon cancers, and cholangiocarcinoma (Figure 1A).